M. Yoo

发表

Transport of a new erectogenic udenafil in caco-2 cells

E. Park, H. Lee, H. Ji, 2007, Archives of pharmacal research.

Effects of DA-6034 on aqueous tear fluid secretion and conjunctival goblet cell proliferation.

S. Choi, M. Yoo, Yeong-Geon Lee, 2009, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.

Inhibitory Effects of 7‐Carboxymethyloxy‐3′,4′,5‐Trimethoxy Flavone (DA‐6034) on Helicobacter pylori‐Induced NF‐κB Activation and iNOS Expression in AGS Cells

K. Hahm, Jeffrey A. Johnson, Y. Surh, 2007, Annals of the New York Academy of Sciences.

Anti-diabetic effects of DA-11004, a synthetic idpc inhibitor in high fat high sucrose Diet-Fed C57BL/6J mice

T. Huh, M. Son, Won Bae Kim, 2004, Archives of pharmacal research.

DA-9201 shows anti-asthmatic effects by suppressing NF-кB expression in an ovalbumin-lnduced mouse model of asthma

J. Kwon, Seung-Ho Lee, S. Choi, 2005, Archives of pharmacal research.

Microarray analysis of gene expression profile in the corpus cavernosum of hypercholesterolemic rats after chronic treatment with PDE5 inhibitor.

J. Kwon, M. Yoo, K. Kang, 2007, Life sciences.

Role of human cytochrome P450 3A4 in the metabolism of DA–8159, a new erectogenic

W. B. Kim, H. Ji, H. Lee, 2004, Xenobiotica; the fate of foreign compounds in biological systems.

DA-8159, a new PDE5 Iihibitor, induces penile erection in conscious and acute spinal cord injured rabbits.

W. Kim, M. Yoo, K. Kang, 2003, European urology.

Erectile potentials of a new phosphodiesterase type 5 inhibitor, DA-8159, in diet-induced obese rats.

M. Yoo, K. Kang, J. Yu, 2006, Asian journal of andrology.

Mechanism of erectogenic effect of the selective phosphodiesterase type 5 inhibitor, DA-8159

M. Son, Won Bae Kim, J. Ko, 2002, Archives of pharmacal research.

In Vitro and In Vivo Activities of DA-7867, a New Oxazolidinone, against Aerobic Gram-Positive Bacteria

E. Choi, Eun-Jeong Yoon, M. Shim, 2005, Antimicrobial Agents and Chemotherapy.

Beneficial effects of the combination of amlodipine and losartan for lowering blood pressure in spontaneously hypertensive rats

S. Choi, M. Yoo, K. Kang, 2009, Archives of pharmacal research.

Effect of Udenafil on Portal Venous Pressure and Hepatic Fibrosis in Rats

Ju-Mi Kim, S. Choi, M. Yoo, 2009, Arzneimittelforschung.

Interaction between udenafil and tamsulosin in rats: non‐competitive inhibition of tamsulosin metabolism by udenafil via hepatic CYP3A1/2

M. Yoo, Y. Kim, He-Kyung Kang, 2009, British journal of pharmacology.

Effects of water deprivation on the pharmacokinetics of DA-8159, a new erectogenic, in rats.

Ji Young Kim, Myung G. Lee, Yu C. Kim, 2006, Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques.

The Therapeutic Effect of DA-6034 on Ocular Inflammation via Suppression of MMP-9 and Inflammatory Cytokines and Activation of the MAPK Signaling Pathway in an Experimental Dry Eye Model

M. J. Lee, J. M. Kim, M. Yoo, 2010, Current eye research.

Inhibitory effect of DA-9201, an extract of Oryza sativa L., on airway inflammation and bronchial hyperresponsiveness in mouse asthma model.

J. Kwon, Seung-Ho Lee, M. Yoo, 2006, Biological & pharmaceutical bulletin.

Udenafil enhances the recovery of erectile function and ameliorates the pathophysiological consequences of cavernous nerve resection.

M. Yoo, K. Kang, B. Ahn, 2010, The journal of sexual medicine.

Gastroretentive drug delivery system of DA-6034, a new flavonoid derivative, for the treatment of gastritis.

Sung Hyun Park, Kang-Choon Lee, D. Na, 2008, International journal of pharmaceutics.

Pharmacokinetics of 7‐carboxymethyloxy‐3‘,4’,5‐trimethoxy flavone (DA‐6034), a derivative of flavonoid, in mouse and rat models of chemically‐induced inflammatory bowel disease

E. J. Kim, Myung G. Lee, J. Kwon, 2006, The Journal of pharmacy and pharmacology.

Determination of a new phosphodiesterase V inhibitor, DA-8159, in plasma and urine by high-performance liquid chromatography.

So H. Kim, Myung G. Lee, J. Kwon, 2002, Journal of pharmaceutical and biomedical analysis.

Negligible pharmacokinetic interaction between oral DA‐8159, a new erectogenic, and amlodipine in rats

E. J. Kim, Myung G. Lee, J. Kwon, 2006, Biopharmaceutics & drug disposition.

Simultaneous determination of a new phosphodiesterase-5 inhibitor DA-8159 and its active metabolite in human plasma by high performance liquid chromatography with tandem mass spectrometry

Sook jin Kim, Won Bae Kim, H. Ji, 2003 .

Penile erectile responses to electric stimulation are enhanced by a new phosphodiesterase type‐5 inhibitor

J. Kwon, M. Yoo, K. Kang, 2005, International journal of urology : official journal of the Japanese Urological Association.

Erectogenic effect of the selective phosphodiesterase type 5 inhibitor, DA-8159

W. Kim, T. Oh, M. Yoo, 2000, Archives of pharmacal research.

Factors influencing the protein binding of a new phosphodiesterase V inhibitor, DA-8159, using an equilibrium dialysis technique.

J. Kwon, H. Shim, M. Lee, 2000, Biopharmaceutics & drug disposition.

Pharmacokinetics, stability, and blood partition of DA-8159, a new phosphodiesterase V inhibitor.

H. S. Lee, J. Kwon, H. Shim, 2000, Research communications in molecular pathology and pharmacology.

DA-8159 : Erectogenic

Yu C. Kim, M. Lee, M. Yoo, 2005 .

The effect of DA-8159, a novel PDE5 inhibitor, on erectile function in the rat model of hypercholesterolemic erectile dysfunction

J. Kwon, J. Y. Yu, M. Yoo, 2005, International Journal of Impotence Research.

Simultaneous determination of sildenafil and its active metabolite UK-103,320 in human plasma using liquid chromatography-tandem mass spectrometry.

Sook jin Kim, Won Bae Kim, H. Lee, 2003, Journal of pharmaceutical and biomedical analysis.

Pharmacokinetics of DA-6034, an agent for inflammatory bowel disease, in rats and dogs: Contribution of intestinal first-pass effect to low bioavailability in rats.

Myung G. Lee, J. Kwon, Hye J. Chung, 2006, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

Gender differences in the pharmacokinetics of DA-6034, a derivative of flavonoids, in rats.

J. Kwon, M. Lee, S. Bae, 2006, Biopharmaceutics & drug disposition.

Effect of DA-6034, a derivative of flavonoid, on experimental animal models of inflammatory bowel disease

I. Song, M. Son, You Sun Kim, 1999, Archives of pharmacal research.

Gastroprotective Effects of DA-6034, a New Flavonoid Derivative, in Various Gastric Mucosal Damage Models

S. Choi, M. Yoo, K. Kang, 2007, Digestive Diseases and Sciences.

Pharmacokinetics of DA‐7218, a new oxazolidinone, and its active metabolite, DA‐7157, after intravenous and oral administration of DA‐7218 and DA‐7157 to rats

Myung G. Lee, S. Bae, Si-hyung Yang, 2007, The Journal of pharmacy and pharmacology.

Effects of water deprivation for 72 hours on the pharmacokinetics of DA‐7867, a new oxazolidinone, in rats

Yu C. Kim, J. Kwon, M. Lee, 2006, Biopharmaceutics & drug disposition.

Long-acting interferon-alpha 2a modified with a trimer-structured polyethylene glycol: preparation, in vitro bioactivity, in vivo stability and pharmacokinetics.

Y. Youn, Kang-Choon Lee, E. Choi, 2006, International journal of pharmaceutics.